RENB
Lunai Bioworks Inc. Common Stock
stockNASDAQ
InactiveSep 30, 2025
1.42USD+12.164%(+0.15)896,298
Loading…
Loading…
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Los Angeles, California, USA
Sep 30, 2025 · 1-for-10 (reverse)
RENB Profile
enochian biosciences (formerly dandrit biotech usa inc.) a biopharmaceutical company, focuses on the development and commercialization of novel therapies aimed to change the course of immunotherapy treatments for hiv/aids and cancer. the company's lead candidate eno-1001 (pre-ind) is a potentially sterilizing cure for hiv/aids. eno-2001 is an hiv vaccine in preclinical stage, and its additional compounds eno-4001 (phase three asset), eno-4002, eno-5001, and eno-3001 are in discovery stages for prevention relapse in colon cancer patients. enochian biosciences is headquartered in los angeles, california.
RENB Performance
| Period | Price | Date | Change |
|---|